VANGUARD GROUP INC - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$31,134,134
-22.9%
4,667,786
+4.8%
0.00%0.0%
Q2 2023$40,365,499
+25.4%
4,455,353
+0.6%
0.00%0.0%
Q1 2023$32,189,997
+0.5%
4,427,785
+0.8%
0.00%0.0%
Q4 2022$32,017,118
+6.9%
4,391,923
+13.3%
0.00%0.0%
Q3 2022$29,957,000
+27.6%
3,875,322
+12.4%
0.00%0.0%
Q2 2022$23,486,000
-7.9%
3,448,705
+7.8%
0.00%0.0%
Q1 2022$25,506,000
+219.3%
3,200,215
+124.4%
0.00%
Q4 2021$7,987,000
-28.8%
1,426,175
-2.3%
0.00%
Q3 2021$11,224,0001,459,5770.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 3,383,029$24,594,6214.83%
Velan Capital Investment Management LP 494,136$3,592,3693.06%
BVF INC/IL 10,563,748$76,798,4482.81%
JOHNSON & JOHNSON 1,000,000$7,270,0002.36%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,925,7071.16%
PFM Health Sciences, LP 3,204,790$23,298,8231.03%
Pier Capital, LLC 862,736$6,272,0910.95%
Boxer Capital, LLC 2,500,000$18,1750.89%
Deep Track Capital, LP 2,345,073$17,048,6810.70%
SILVERARC CAPITAL MANAGEMENT, LLC 198,477$1,442,9280.60%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders